T1	Pharmacological_substance 15 24	ritonavir
N1000 	Reference T1 MeSH:D019438	ritonavir
T2	Disorder 33 55	maculopapular eruption
N1 	Reference T2 UMLS:C0423791	maculopapular eruption
T3	Disorder 79 101	maculopapular eruption
N2 	Reference T3 UMLS:C0423791	maculopapular eruption
T4	Disorder 106 111	fever
N3 	Reference T4 UMLS:C0015967	fever
T5	Disorder 138 166	human immunodeficiency virus
N4 	Reference T5 UMLS:C3854222	human immunodeficiency virus
T6	Pharmacological_substance 215 224	ritonavir
N1001 	Reference T6 MeSH:D019438	ritonavir
T7	Pharmacological_substance 228 246	protease inhibitor
N1002 	Reference T7 MeSH:D011480	protease inhibitor
T8	Pharmacological_substance 428 437	Ritonavir
N1003 	Reference T8 MeSH:D019438	Ritonavir
T9	Disorder 522 525	HIV
N5 	Reference T9 UMLS:C3854222	HIV
T11	Subject 526 534	patients
T12	Subject 115 123	patients
T13	Disorder 168 171	HIV
N6 	Reference T13 UMLS:C3854222	HIV
T14	Subject 255 266	1st patient
T15	Disorder 491 518	adverse cutaneous reactions
T17	Speculation_cue 480 483	can
T18	Subject 342 345	2nd
